S100A7 (Psoriasin), highly expressed in Ductal Carcinoma In Situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Petersson, Stina ^a   Bylander, Anna ^a   Yhr, Maria ^a   Enerbäck, Charlotta ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PSORIASIN; STAT1 PROTEIN; TETRACYCLINE; CALCIUM BINDING PROTEIN; CALGRANULIN A; CALGRANULIN B; S100A7 PROTEIN, HUMAN; STAT1 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST EPITHELIUM; CANCER CELL CULTURE; CARCINOMA IN SITU; CONTROLLED STUDY; GENE EXPRESSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; ONE TAILED TEST; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PSORIASIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; WESTERN BLOTTING; ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; BIOSYNTHESIS; BREAST; BREAST TUMOR; CELL CULTURE; CELL SURVIVAL; EPITHELIUM; METABOLISM; PHENOTYPE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BREAST; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CALGRANULIN A; CALGRANULIN B; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; EPITHELIUM; GENE EXPRESSION REGULATION; INTERFERON TYPE II; MICE; MODELS, BIOLOGICAL; NF-KAPPA B; PHENOTYPE; STAT1 TRANSCRIPTION FACTOR;

EID: 38049110002     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-205     Document Type: Article

References (30)

1. Watson PH Leygue ER Murphy LC Psoriasin (S100A7) Int J Biochem Cell Biol 1998, 30:567-571 10.1016/S1357-2725(97)00066-6 9693957
2. Al-Haddad S Zhang Z Leygue E Snell L Huang A Niu Y Hiller-Hitchcock T Hole K Murphy LC Watson PH Psoriasin (S100A7) expression and invasive breast cancer Am J Pathol 1999, 155:2057-2066 1866920 10595935
3. Enerback C Porter DA Seth P Sgroi D Gaudet J Weremowicz S Morton CC Schnitt S Pitts RL Stampl J Barnhart K Polyak K Psoriasin expression in mammary epithelial cells in vitro and in vivo Cancer Res 2002, 62:43-47 11782356
4. Leygue E Snell L Hiller T Dotzlaw H Hole K Murphy LC Watson PH Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma Cancer Res 1996, 56:4606-4609 8840971
5. Porter DA Krop IE Nasser S Sgroi D Kaelin CM Marks JR Riggins G Polyak K A SAGE (serial analysis of gene expression) view of breast tumor progression Cancer Res 2001, 61:5697-5702 11479200
6. Emberley ED Niu Y Leygue E Tomes L Gietz RD Murphy LC Watson PH Psoriasin interacts with Jab1 and influences breast cancer progression Cancer Res 2003, 63:1954-1961 12702588
7. Carlsson H Yhr M Petersson S Collins N Polyak K Enerback C Psoriasin (S100A7) and Calgranulin-B (S100A9) Induction is Dependent on Reactive Oxygen Species and is Downregulated by Bcl-2 and Antioxidants Cancer Biol Ther 2005, 4:998-1005 16082188
8. Emberley ED Niu Y Curtis L Troup S Mandal SK Myers JN Gibson SB Murphy LC Watson PH The S100A7-c-Jun activation domain binding protein 1 pathway enhances prosurvival pathways in breast cancer Cancer Res 2005, 65:5696-5702 10.1158/0008-5472.CAN-04-3927 15994944
9. Krop I Marz A Carlsson H Li X Bloushtain-Qimron N Hu M Gelman R Sabel MS Schnitt S Ramaswamy S Kleer CG Enerback C Polyak K A putative role for psoriasin in breast tumor progression Cancer Res 2005, 65:11326-11334 10.1158/0008-5472.CAN-05-1523 16357139
10. Jinquan T Vorum H Larsen CG Madsen P Rasmussen HH Gesser B Etzerodt M Honore B Celis JE Thestrup-Pedersen K Psoriasin: A novel chemotactic protein J Invest Dermatol 1996, 107:5-10 10.1111/1523-1747.ep12294284 8752830
11. Glaser R Harder J Lange H Bartels J Christophers E Schroder JM Antimicrobial psoriasin (S100A7) protects human skin from Escherichia coli infection Nat Immunol 2005, 6:57-64 10.1038/ni1142 15568027
12. Madsen P Rasmussen HH Leffers H Honore B Dejgaard K Olsen E Kiil J Walbum E Andersen AH Basse B Lauridsen J Ratz G Celis A Vandekerckhove J Celis J Molecular cloning, occurrence, and expression of a novel partially secreted protein "psoriasin" that is highly up-regulated in psoriatic skin J Invest Dermatol 1991, 97:701-712 10.1111/1523-1747.ep12484041 1940442
13. Celis JE Cruger D Kiil J Lauridsen JB Ratz G Basse B Celis A Identification of a group of proteins that are strongly up-regulated in total epidermal keratinocytes from psoriatic skin FEBS Lett 1990, 262:159-164 10.1016/0014-5793(90)80179-M 2185946
14. Gudjonsson JE Johnston A Sigmundsdottir H Valdimarsson H Immunopathogenic mechanisms in psoriasis Clin Exp Immunol 2004, 135:1-8 1808928 14678257 10.1111/j.1365-2249.2004.02310.x
15. Beckmann MW Niederacher D Schnurch HG Gusterson BA Bender HG Multistep carcinogenesis of breast cancer and tumour heterogeneity J Mol Med 1997, 75:429-439 10.1007/s001090050128 9231883
16. Chawla-Sarkar M Lindner DJ Liu YF Williams BR Sen GC Silverman RH Borden EC Apoptosis and interferons: Role of interferon-stimulated genes as mediators of apoptosis Apoptosis 2003, 8:237-249 10.1023/A:1023668705040 12766484
17. Ruiz-Ruiz C Munoz-Pinedo C Lopez-Rivas A Interferon-gamma treatment elevates caspase-8 expression and sensitizes human breast tumor cells to a death receptor-induced mitochondria-operated apoptotic program Cancer Res 2000, 60:5673-5680 11059759
18. Stark GR Kerr IM Williams BR Silverman RH Schreiber RD How cells respond to interferons Annu Rev Biochem 1998, 67:227-264 10.1146/ annurev.biochem.67.1.227 9759489
19. Ovstebo R Haug KB Lande K Kierulf P PCR-based calibration curves for studies of quantitative gene expression in human monocytes: Development and evaluation Clin Chem 2003, 49:425-432 10.1373/49.3.425 12600954
20. Martinsson H Yhr M Enerback C Expression patterns of S100A7 (psoriasin) and S100A9 (calgranulin-B) in keratinocyte differentiation Exp Dermatol 2005, 14:161-168 10.1111/j.0906-6705.2005.00239.x 15740587
21. Darnell JE Jr Kerr IM Stark GR Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins Science 1994, 264:1415-1421 10.1126/science.8197455 8197455
22. Shtrichman R Samuel CE The role of gamma interferon in antimicrobial immunity Curr Opin Microbiol 2001, 4:251-259 10.1016/ S1369-5274(00)00199-5 11378475
23. Widschwendter A Tonko-Geymayer S Welte T Daxenbichler G Marth C Doppler W Prognostic significance of signal transducer and activator of transcription 1 activation in breast cancer Clin Cancer Res 2002, 8:3065-3074 12374673
24. Seymour L Bezwoda WR Interferon plus tamoxifen treatment for advanced breast cancer: In vivo biologic effects of two growth modulators Br J Cancer 1993, 68:352-356 8347490
25. Nanni P Nicoletti G De Giovanni C Landuzzi L Di Carlo E Iezzi M Ricci C Astolfi A Croci S Marangoni F Musiani P Forni G Lollini PL Prevention of HER-2/neu transgenic mammary carcinoma by tamoxifen plus interleukin 12 Int J Cancer 2003, 105:384-389 10.1002/ijc.11092 12704673
26. Chatterji U Riby JE Taniguchi T Bjeldanes EL Bjeldanes LF Firestone GL Indole-3-carbinol stimulates transcription of the interferon gamma receptor 1 gene and augments interferon responsiveness in human breast cancer cells Carcinogenesis 2004, 25:1119-1128 10.1093/carcin/bgh121 14988219
27. Carlsson H Petersson S Enerback C Cluster analysis of S100 gene expression and genes correlating to psoriasin (S100A7) expression at different stages of breast cancer development Int J Oncol 2005, 27:1473-1481 16273201
28. Bodis S Siziopikou KP Schnitt SJ Harris JR Fisher DE Extensive apoptosis in ductal carcinoma in situ of the breast Cancer 1996, 77:1831-1835 10.1002/(SICI)1097-0142(19960501)77:9<1831::AID-CNCR11>3.0.CO;2-0 8646681
29. Van Antwerp DJ Martin SJ Kafri T Green DR Verma IM Suppression of TNF-alpha-induced apoptosis by NF-kappaB Science 1996, 274:787-789 10.1126/science.274.5288.787 8864120
30. Battle TE Lynch RA Frank DA Signal transducer and activator of transcription 1 activation in endothelial cells is a negative regulator of angiogenesis Cancer Res 2006, 66:3649-3657 10.1158/ 0008-5472.CAN-05-3612 16585190